Department of Commerce Under Secretary for Industry and Security Jeffrey Kessler

Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton

by | May 12, 2026
When completed in 2028, the company’s first Texas‑based manufacturing facility will bring RLT medications closer to patients across the southern United States, becoming the fifth RLT site nationwide, Novartis said.
MORE